Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 3

Conditions

Breast Neoplasms 9459Neoplasms 6577Prostatic Neoplasms 4394Colorectal Neoplasms 3964Lung Neoplasms 3633Carcinoma, Non-Small-Cell Lung 3576Pancreatic Neoplasms 2472Carcinoma, Hepatocellular 2407Leukemia, Myeloid, Acute 2261Multiple Myeloma 2115Stomach Neoplasms 2104Neoplasm Metastasis 1911Head and Neck Neoplasms 1864Ovarian Neoplasms 1770Precursor Cell Lymphoblastic Leukemia-Lymphoma 1732Lymphoma 1728Brain Neoplasms 1696Rectal Neoplasms 1672Melanoma 1652Colonic Neoplasms 1629Leukemia 1498Uterine Cervical Neoplasms 1493Recurrence 1480Esophageal Neoplasms 1309Glioblastoma 1303Lymphoma, Non-Hodgkin 1202Leukemia, Lymphocytic, Chronic, B-Cell 1120Squamous Cell Carcinoma of Head and Neck 1108Urinary Bladder Neoplasms 1077Lymphoma, Follicular 1067

Interventions

apalutamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Low Risk Prostate Cancer × Clear all
NCT01877070 2026-05-06

Decision Making in Men With Early Stage Prostate Cancer Patients and Partners/Close Allies

Memorial Sloan Kettering Cancer Center

Active not recruiting
541 enrolled
Genitourinary

Low Risk Prostate Cancer

NCT03088124 2026-03-20

PC-ARN

Institut Paoli-Calmettes

Phase 2 Completed
93 enrolled
Genitourinary

Low Risk Prostate Cancer

NCT03849365 2021-03-23

Study of Erectile Dysfunction, Urinary Incontinence and Related QoL After TOOKAD® VTP for Low Risk Prostate Cancer

Steba Biotech S.A.

Phase 4 Terminated
23 enrolled
Genitourinary

Low Risk Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡